Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.220
+0.030 (1.37%)
At close: Dec 20, 2024, 4:00 PM
2.260
+0.040 (1.80%)
After-hours: Dec 20, 2024, 5:48 PM EST
BDTX Market Cap
BDTX has a market cap or net worth of $125.62 million as of December 20, 2024. Its market cap has decreased by -5.34% in one year.
Market Cap
125.62M
Enterprise Value
35.94M
1-Year Change
-5.34%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $125.62M, a decrease of -90.73%. That is a compound annual growth rate of -38.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 125.62M | -13.42% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | 1.15B | -14.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 132.21M |
| Protalix BioTherapeutics | 129.23M |
| InflaRx | 127.78M |
| Atossa Therapeutics | 124.57M |
| Enanta Pharmaceuticals | 123.99M |
| Akoya Biosciences | 123.41M |
| Elutia | 121.66M |
| TriSalus Life Sciences | 119.53M |